The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Sees Large Increase in Short Interest

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the recipient of a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 23,400 shares, an increase of 216.2% from the December 15th total of 7,400 shares. Based on an average daily trading volume, of 28,300 shares, the short-interest ratio is currently 0.8 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Trading Down 0.7 %

Shares of Carlyle Group Inc. 4.625% Subordinated Notes due 2061 stock opened at $17.88 on Tuesday. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a 52-week low of $17.48 and a 52-week high of $20.85. The company’s 50-day simple moving average is $18.76 and its 200-day simple moving average is $19.14.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Saturday, February 15th. Shareholders of record on Saturday, February 1st will be given a dividend of $0.2891 per share. This is a boost from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29. The ex-dividend date is Friday, January 31st. This represents a $1.16 annualized dividend and a yield of 6.47%.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.